100% Quality Guarantee
PhD-Level Technical Support
Key Features

Mouse SARS-CoV-2 Spike RBD Delta (B.1.617.2) IgG ELISA Kit (AEFI00692)

SKU AEFI00692
Product Type ELISA Kit
Size 96 Assays
Sensitivity 0.938ng/ml
Range 1.563-100ng/ml
ELISA Type Indirect
Reactivity Mouse
$857 - $7,710

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

Mouse SARS-CoV-2 Spike RBD Delta (B.1.617.2) IgG ELISA Kit

The Mouse Anti-SARS-CoV-2 S RBD Delta (B.1.617.2) IgG ELISA Kit is a highly sensitive and specific tool designed for the accurate detection of IgG antibodies against the SARS-CoV-2 Spike protein receptor-binding domain (RBD) variant Delta (B.1.617.2) in mouse serum, plasma, and cell culture supernatants. This kit provides reliable and reproducible results, making it an ideal choice for a wide range of research applications.The Spike protein of SARS-CoV-2 is a key target for vaccine development and antibody therapies, and monitoring specific antibodies against different variants, such as Delta (B.

1.617.2), is crucial for understanding immune responses and virus evolution. The Mouse Anti-SARS-CoV-2 S RBD Delta (B.1.617.2) IgG ELISA Kit allows for the accurate quantification of IgG antibodies targeting this variant, facilitating research on virus neutralization, immune responses, and vaccine efficacy.Overall, this ELISA kit is a valuable tool for researchers studying SARS-CoV-2 and its variants, contributing to the development of effective strategies for combating the ongoing COVID-19 pandemic.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose